Journal of Bacteriology, March 2001, p. 1540-1551, Vol. 183, No. 5
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.5.1540-1551.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9048
Received 5 May 2000/Accepted 3 December 2000
| |
ABSTRACT |
|---|
|
|
|---|
The UspA1 protein of Moraxella catarrhalis has been shown to function as an adhesin that mediates adherence to human epithelial cell lines in vitro (E. R. Lafontaine, L. D. Cope, C. Aebi, J. L. Latimer, G. H. McCracken, Jr., and E. J. Hansen, J. Bacteriol. 182:1364-1373, 2000). In the present study, cell lysates prepared from individual colonies of several M. catarrhalis wild-type strains were analyzed by Western blot analysis using monoclonal antibodies (MAbs) specific for the UspA1 protein. Expression of UspA1 was shown to exhibit phase variation that was correlated with both adherence ability in vitro and the number of guanine (G) residues contained within a homopolymeric [poly(G)]tract located upstream of the uspA1 open reading frame (ORF). Nucleotide sequence analysis revealed that isolates expressing relatively high levels of UspA1 had 10 G residues in their uspA1 poly(G)tracts, whereas isolates that expressed much lower levels of UspA1 had 9 G residues. This poly(G) tract was located 30 nucleotides (nt) upstream of the uspA1 ORF and 168 nt downstream of the uspA1 transcriptional start site. Primer extension experiments, RNA slot blot analysis, and cat reporter constructs were used to demonstrate that M. catarrhalis isolates with 10 G residues in their uspA1 poly(G) tracts expressed two-to threefold more uspA1 mRNA than did isolates which had 9 G residues in their poly(G)tracts. Northern hybridization analysis revealed that an intact uspA1 mRNA was readily detectable in RNA from M. catarrhalis isolates that had 10 G residues in their uspA1 poly(G) tracts, whereas no full-length uspA1 mRNA was observed in isolates whose poly(G)tracts contained 9 G residues. M. catarrhalis strain O35E uspA1 genes that contained wild-type and mutated poly(G) tracts were expressed in Haemophilus influenzae to demonstrate that the length and composition of the poly(G)tract affected expression of UspA1.
| |
INTRODUCTION |
|---|
|
|
|---|
Moraxella (Branhamella) catarrhalis is an unencapsulated gram-negative bacterium that can cause both upper and lower respiratory tract infections (14, 33). It has been estimated that M. catarrhalis causes approximately 20% of cases of acute bacterial otitis media in infants and young children (5) and is associated with nearly 30% of infectious exacerbations of chronic obstructive pulmonary disease in adults (17). The significant morbidity associated with M. catarrhalis infections as well as the substantial health care costs of these infections have prompted recent interest in the development of an M. catarrhalis vaccine (37).
Proteins present in or closely associated with the outer membrane of M. catarrhalis strains obtained from diverse geographic and clinical sources display highly similar patterns when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (4) and have received the most attention as potential vaccine candidates. Several of these cell surface-exposed proteins have been characterized in some detail, including UspA1, UspA2 (HMWP), and UspA2H (24, 26, 32); OMP CD (21, 34); the iron-regulated CopB protein (3, 8); the LbpA and LbpB proteins (6); and the TbpA and TbpB proteins (7, 28, 35).
Little is known about the regulation of expression of M. catarrhalis outer membrane proteins. Campagnari et al. (8) were the first to show that the availability of iron in the growth medium affected expression of several M. catarrhalis outer membrane proteins. A spontaneous mutant of M. catarrhalis that lacked the ability to express several different outer membrane antigens was described by Murphy and coworkers (25). In addition, it was reported that one strain of M. catarrhalis could give rise to variants that expressed a truncated UspA2 protein (K. R. VanDerMeid, S. M. Baker, and J. C. McMichael, Abstr. 99th Gen. Meet. Am. Soc. Microbiol. 1999, abstr. D/B-289, p. 256, 1999). Most recently, it was reported that the 200-kDa surface protein of this organism, which may be involved in hemagglutination (15), underwent phase-variable expression that involved apparent slipped-strand mispairing in a homopolymeric nucleotide repeat located within the open reading frame (ORF) encoding this protein. (K. Sasaki, L. Myers, S. M. Loosmore, and M. H. Klein, Abstr. 99th Gen. Meet. Am. Soc. Microbiol., 1999, abstr. B/D-306, p. 89, 1999).
The UspA1 surface protein of M. catarrhalis is synthesized as an 80- to 90-kDa monomer that forms very large aggregates or complexes that are relatively resistant to heating in the presence of SDS (12, 32). This protein also has been shown to mediate attachment of this bacterium to Chang conjunctival epithelial cells in vitro (26). In the present study, expression of the M. catarrhalis UspA1 protein was found to exhibit phase variation. Nucleotide sequence analysis indicated that this phenotypic switch could be correlated with changes in the length of a homopolymeric nucleotide [poly(G)] tract located upstream of the uspA1 ORF. Primer extension, RNA slot blot, and Northern hybridization experiments revealed that UspA1 expression was regulated at the level of transcription. Cloning and expression of uspA1 genes in Haemophilus influenzae revealed that the changes in the length of the poly(G) tract were sufficient to account for the phase-variable expression of UspA1.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, plasmids, and culture conditions.
Bacterial strains and plasmids are listed in Table
1. M. catarrhalis
(2) and H. influenzae (16) strains
were cultured as described earlier. Recombinant H. influenzae and E. coli strains were selected with
chloramphenicol (2 and 10 µg/ml, respectively). The M. catarrhalis mutants containing the chloramphenicol
acetyltransferase (CAT) reporter gene (cat) were selected
with chloramphenicol (0.6 µg/ml). For adherence assays, RNA isolation
experiments, and measurement of cat reporter activity,
strains were grown in broth without antibiotic supplementation for
several (three to four) generations.
|
Recombinant DNA techniques.
Standard molecular biology
methods were performed as described previously (38). The
H. influenzae Rd strain DB117 was used as the host strain
for most recombinant DNA manipulations; Escherichia coli
DH5
was used where noted. Electroporation was carried out as
described earlier (26). DNA fragments used in cloning
experiments, as templates for nucleotide sequence analysis, or as
probes in hybridization experiments were purified with the Wizard PCR
Preps system (Promega Corp., Madison, Wis.) after electrophoresis in agarose gels. Plasmid DNA was purified with the Wizard Plus Minipreps or Midipreps systems (Promega).
PCR. DNA probes for Northern and RNA slot blot hybridization experiments were generated with Taq DNA polymerase (Promega). The 579-bp uspA1 probe was amplified from M. catarrhalis O35E with the oligonucleotide primers P1 (5'-AGGGATCCCCGTCCCCCTAATAAGTGAG-3'; BamHI site underlined) and P2 (5'-AACTCGAGTTGAACCTGTACCTGTGGCTTGG-3'; XhoI site underlined), whereas primers P3 (5'-AGGCATGCTTATGCTGGCTTTTGTC-3'; SphI site underlined) and P4 (5'-ACCTCGAGTTTAGCACTCTCTTTTGG-3'; XhoI site underlined) were used to generate the 503-bp uspA2 probe. The oligonucleotide primers P5 (5'-CGGCATGCCGGGTGACTAACTAGAGG-3') and P6 (5'-CGGCATGCTCCTTCCAGAAATTACGC-3') were used to amplify a 695-bp probe for the cat gene from pSL1. The Tm for the uspA1 probe was 78.4°C, while that of the uspA2 probe was 78.1°C, and that of the cat probe was 77.4°C. DNA fragments used for nucleotide sequence analysis were amplified with the Gene Amp XL PCR kit (Perkin-Elmer Biosystems, Branchburg, N.J.) according to the manufacturer's specifications. Amplicons used for cloning of uspA1 genes in H. influenzae were generated with Pfu DNA polymerase (Stratagene, La Jolla, Calif.) using the primers P7 (5'-AGGGATCCAACGACGGTCCAAGATGG-3'; BamHI site underlined) and P8 (5'-AGGGATCCCCTGCCACCTAAAGCCTTG-3'; BamHI site underlined) or P9 (5'-AGGGATCCGGAGACCCCAGTCATTTATTAG-3'; BamHI site underlined) and P8.
Construction of uspA1::cat
reporter fusions.
Plasmid pUSPA1, which contains an incomplete
uspA1 ORF from M. catarrhalis O35E
(2) inserted into the multiple cloning site downstream
from and in the same orientation as the plasmid-based lac
promoter, was digested with BglII to remove a 0.6-kb
internal fragment, and the BglII ends were then filled in
with Pfu DNA polymerase using the manufacturer's
recommended conditions. The resulting blunt-ended pUSPA1 plasmid was
then ligated with a 706-bp SmaI fragment containing the
promoterless cat gene from plasmid pSL1 (29).
The ligation mixture was used to electroporate E. coli
DH5
, and recombinant clones were selected for resistance to
chloramphenicol; the plasmids in these recombinants had the cat insert oriented in the same direction as the
plasmid-based lac promoter. Nucleotide sequence analysis of
one of these, designated pELU1CAT, confirmed that the promoterless
cat gene had been introduced in the direction of
transcription of the uspA1 gene. Plasmid pELU1CAT was used
to electroporate M. catarrhalis isolates O35E.118 and O35E.135. Chloramphenicol-resistant transformants were screened by PCR
to identify those containing a
uspA1::cat transcriptional fusion in
the chromosome. Allelic exchange was confirmed by Southern blot
analysis of two of these transformants, O35E.118CAT and O35E.135CAT. Nucleotide sequence analysis of the entire
uspA1::cat gene of M. catarrhalis O35E.118CAT (including 300 nucleotides [nt] upstream of the translational start codon) revealed that it was identical to
that in O35E.135CAT except that the poly(G) tract of the former contained 10 G residues, whereas the poly(G) tract of the latter had
only 9 G residues.
Northern and slot blot hybridization analysis.
Total RNA was
isolated from bacterial cells by use of the RNAWIZ reagent (Ambion,
Austin, Tex.). For Northern hybridization analysis, RNA samples (20 µg) were electrophoresed into a denaturing (i.e., formaldehyde)
agarose gel and transferred to a HybondN+ membrane (Amersham Pharmacia)
as described elsewhere (38). For slot blot hybridization
experiments, RNA samples were prepared as described previously
(38) and transferred to a Nytran SuperCharge membrane
(Schleicher & Schuell, Keene, N.H.) using a MINIFOLD 1 microsample
filtration manifold (Schleicher & Schuell) as specified by the
manufacturer. Hybridization was performed at 42°C for 18 h in
ULTRAhyb hybridization buffer (Ambion). mRNAs were detected by
autoradiography. The uspA1, uspA2, and cat probes
were radioactively labeled with [
-32P]dCTP (NEN,
Boston, Mass.) by use of a random-primed DNA labeling kit
(Boehringer-Mannheim GmbH) according to the manufacturer's protocol.
For one experiment, uspA1 and cat riboprobes were
generated with the MaxiScript T7 kit (Ambion).
Primer extension analysis.
Primer extension experiments were
performed with the avian myeloblastosis virus (AMV) reverse
transcriptase (RT) Primer Extension System (Promega) according to the
manufacturer's recommended procedure with the exception that the AMV
RT supplied with this system was replaced by the RNA-dependent Moloney
murine leukemia virus (MMLV) RT enzyme (Promega) for the synthesis of
cDNA. The oligonucleotide primers P10 and P11 (Fig. 2B) were
radioactively labeled with [
-32P]dATP (NEN).
Nucleotide sequence analysis was carried out with the AmpliCycle
sequencing kit (Perkin-Elmer) and the radioactively labeled primers P10
and P11.
Nucleotide sequence analysis. The nucleotide sequence of the PCR products and recombinant plasmids described in this study was determined with an Applied Biosystems model 373A automated DNA sequencer (Applied Biosystems, Foster City, Calif.). Nucleotide sequence information was analyzed with the SeqEd v1.0.3 (Applied Biosystems) and AssemblyLIGN and Mac Vector (version 6.5; Oxford Molecular, Ltd., Campbell, Calif.) software packages.
CAT ELISA assay. Expression of CAT by the M. catarrhalis reporter strains O35E.118CAT and O35E.135CAT was quantitatively measured using an enzyme immunoassay (CAT enzyme-linked immunosorbent assay [ELISA]) according to the manufacturer's recommended protocol (Roche Diagnostics GmbH, Mannheim, Germany). Cell extracts were prepared from 1 ml of broth culture grown to a density of 125 Klett units. Serial dilutions of the cell extracts were used in the CAT ELISA to measure the amount of CAT expressed by the reporter strains. Results were normalized with respect to the total protein concentration of the cell extracts as determined by the Markwell modification of the Lowry assay (30).
Cloning and mutagenesis of M. catarrhalis uspA1 genes in H. influenzae. PCR products of approximately 3 kb containing the uspA1 genes from M. catarrhalis isolates O35E.118 and O35E.135 were amplified with the oligonucleotide primers P7 and P8 and Pfu polymerase. A PCR product containing the uspA1 gene lacking the poly(G) tract and upstream DNA was similarly amplified from O35E.135 using the oligonucleotide primers P9 and P8. These amplicons were digested with BamHI and ligated into the BamHI site of the vector pACYC184 (New England Biolabs, Inc., Beverly, Mass.). The ligation reactions were subsequently used to electroporate H. influenzae DB117. Chloramphenicol-resistant colonies were screened for reactivity with the UspA1-reactive monoclonal antibody (MAb) 17C7 in the colony blot radioimmunoassay (RIA). Site-directed mutagenesis of the poly(G) tract in plasmid pELU1-10G was accomplished using the QuikChange Site-Directed Mutagenesis system (Stratagene).
Adherence assays. Adherence assays were performed with Chang conjunctival epithelial cells as previously described (1).
Colony blot RIA and characterization of protein antigens. The colony blot-RIA was performed as described elsewhere (36). Preparation of whole-cell lysates, SDS-PAGE, and Western blot analysis were accomplished as described previously (36). It should be noted that the heating of whole-cell lysates at 100°C for 3 to 5 min will convert the very-high-molecular-weight UspA1 aggregates to a form that has an apparent molecular weight of 120 to 130 kDa in SDS-PAGE (12). The indirect antibody-accessibility assay was performed as described earlier (1).
Densitometric measurements. Densitometric measurements of band intensities in autoradiographs was accomplished by the use of an Alpha Imager 2000 documentation and analysis system (Alpha Innotech Corp., San Leandro, Calif.), together with Alpha Imager software (version 4.0).
MAbs. The UspA1- and UspA2-reactive MAb 17C7 (2), the UspA1-specific MAb 24B5 (12), the UspA2-specific MAb 17H4 (1), and the CopB-specific MAb 10F3 (19) have been described. To obtain a second UspA1-specific MAb, the synthetic peptide ETNNRQDQKIDQLGYALKEQGQHFNNR (PEP1) was synthesized by the Biopolymers Facility at the University of Texas Southwestern Medical Center and covalently bound to keyhole limpet hemocyanin (Sigma Chemical Co., St. Louis, Mo.) using glutaraldehyde. The sequence of PEP1 corresponds to amino acid residues 723 to 749 of the M. catarrhalis O35E UspA1 protein and is highly conserved in all UspA1 proteins characterized to date (data not shown). The PEP1-KLH conjugate was used to immunize mice for hybridoma production as previously described (1); MAb 33B5 was shown by ELISA to bind PEP1 which had been covalently linked to ovalbumin (Sigma) using glutaraldehyde and to specifically bind the UspA1 protein of M. catarrhalis O35E in Western blot analysis. Rat polyclonal antiserum raised against the 39-kDa P2 major outer membrane protein of H. influenzae type b strain DL42 has been described elsewhere (18).
| |
RESULTS |
|---|
|
|
|---|
Variable expression of the M. catarrhalis UspA1
protein.
During construction of isogenic uspA2 mutants
in previous studies (1, 26), it was noted that a few of
these uspA2 mutants underwent an apparent spontaneous change
which resulted in reduced expression of the UspA1 protein (data not
shown). To investigate this phenomenon, whole-cell lysates were
generated from individual colonies (isolates) of the wild-type M. catarrhalis strain O35E and probed in Western blot analysis with
the UspA1-reactive MAbs 33B5 and 24B5. These two different
UspA1-specific MAbs were used independently to detect possible epitope
variation. Some of these individual isolates (O35E.118 and O35E.98;
Fig. 1A and B, lanes 2 and 3, respectively) expressed UspA1 at levels indistinguishable from that
observed with the wild-type parent strain (Fig. 1A and B, lanes 1). In
contrast, expression of the UspA1 protein was dramatically decreased in
other individual isolates (Fig. 1A and B, lanes 4 to 7 containing
isolates O35E.117, O35E.121, O35E.135, and O35E.137, respectively). MAb
10F3, specific for the CopB outer membrane protein (19),
was used to demonstrate that equivalent amounts of whole-cell lysate
had been analyzed (Fig. 1C). In addition, the use of the indirect
antibody accessibility assay indicated that there was significantly
more UspA1 expressed on the surface of the strain O35E.118 than on the
surface of strain O35E.135 (Table 2).
|
|
Variation in expression of UspA1 can be correlated with the length of a poly-G tract. The nucleotide sequences of the several different uspA1 genes characterized to date have a stretch of consecutive guanine (G) residues located 30 nt upstream of the predicted translational start codon (2, 12, 26). Such homopolymeric nucleotide tracts have been previously shown to be directly involved in phase variation of expression of surface-exposed antigens of gram-negative pathogens (20). Thus, the nucleotide sequence of the DNA located directly upstream of the uspA1 ORF was determined for individual M. catarrhalis isolates that expressed different levels of UspA1. The two individual isolates (O35E.118 and O35E.98) that expressed levels of UspA1 equivalent to that of the wild-type strain had 10 G residues in their respective poly(G) tracts (Fig. 1E, lines 2 and 3). In contrast, the four individual isolates that expressed greatly reduced levels of UspA1 (O35E.117, O35E.121, O35E.135, and O35E.137) all had nine G residues in this same region (Fig. 1E, lines 4 to 7). Analysis of individual colonies of M. catarrhalis strains O46E, O12E, and TTA37 revealed the same correlation between relative levels of expression of the UspA1 protein and the number of G residues in the poly(G) tract upstream of the uspA1 ORF (data not shown).
The nucleotide sequences of the uspA1 genes of four isolates, derived from two different M. catarrhalis wild-type strains, were determined in their entirety. Isolates O35E.118 (Fig. 1A and B, lanes 2) and O12E.44 (data not shown) both expressed wild-type levels of UspA1, whereas isolates O35E.135 (Fig. 1A and B, lanes 6) and O12E.77 (data not shown) produced greatly reduced amounts of this protein. Other than differing in the number of residues in their respective poly(G) tracts, the nucleotide sequence of the uspA1 gene of strain O35E.118 was identical to that of O35E.135. Similarly, the sequences of the uspA1 genes of isolates O12E.44 and O12E.77 were identical to each other except in the poly-G tract, where O12E.44 contained 10 G residues, whereas that of O12E.77 contained 9 G residues.The poly-G tract is part of the uspA1 mRNA.
Primer
extension experiments were performed to determine the transcriptional
start site of the uspA1 gene. The use of the oligonucleotide
primer P10 (Fig. 2B) in primer extension
analysis of total RNA isolated from M. catarrhalis O35E.118
yielded a cDNA fragment that was 86 nt in length (Fig. 2A, lane 2).
Nucleotide sequence analysis using P10 mapped the transcriptional start
site of uspA1 to a G residue (Fig. 2A) located 208 nt
upstream from the translational start codon of the uspA1 ORF
(Fig. 2B). Primer extension analysis with the oligonucleotide primer
P11 (Fig. 2B) identified the same G residue as the transcriptional
start site (data not shown). These results indicate that, in an isolate
expressing wild-type levels of UspA1 (i.e., O35E.118), the poly(G)
tract is part of the uspA1 mRNA and is positioned 168 nt
downstream of the transcriptional start site (Fig. 2B). Nucleotide
sequences exhibiting homology to the
10 and
35 consensus sequences
for bacterial promoters were observed upstream of the uspA1
transcriptional start site (Fig. 2B). It should be noted that a
putative uspA1 translational initiation codon (ATG) was
located 34 nt 5' from the poly(G) tract. However, there is no obvious
Shine-Dalgarno sequence preceding this ATG and there is an in-frame TGA
stop codon located immediately before the poly(G) repeat, so it is highly unlikely that translation was initiated from this ATG codon. Furthermore, when site-directed mutagenesis was used to change the
predicted ATG start codon (located downstream from the poly(G) tract)
to ACG, this change abolished expression of UspA1 (data not shown).
|
Slot blot and Northern hybridization analysis of uspA1
transcription in M. catarrhalis.
Slot blot and Northern
hybridization analyses were performed using total RNA obtained from the
M. catarrhalis isolates described above. The DNA probes for
uspA1 and uspA2 mRNA were specific for the 5' end
of each gene. Slot blot hybridization experiments showed that 2.2-fold
more uspA1 mRNA was detected in O35E.118 (10 G) (Fig.
3A, lanes 1 and 3) than in O35E.135 (9 G)
(Fig. 3A, lanes 2 and 4). This effect was observed both in the early
(Fig. 3A, lanes 1 and 2) and mid-logarithmic (Fig. 3A, lanes 3 and 4)
phases of growth. A uspA2-specific probe was used to
demonstrate that equivalent amounts of RNA were analyzed at both time
points (Fig. 3B). Similar results were obtained from slot blot
hybridization analysis of total RNA isolated from M. catarrhalis O12E.44 (10 G) and O12E.77 (9 G) (data not shown).
|
|
Construction of uspA1::cat reporter strains. In order to quantitatively determine the effect of the poly(G) tract on transcription of uspA1, a promoterless cat gene was introduced into the uspA1 gene of the M. catarrhalis isolates O35E.118 (10 G) and O35E.135 (9 G). The resulting reporter strains were designated O35E.118CAT and O35E.135CAT, respectively. Nucleotide sequence analysis confirmed that the promoterless cat gene was inserted in the proper orientation in these two strains and that there were no mutations in the 5' untranslated region of the uspA1 gene.
Slot blot hybridization analysis of total RNA with a uspA1-specific probe (described above) indicated the presence of a two- threefold-greater amount of specific mRNA in O35E.118 (10 G) compared to the amount detected in O35E.135 (9 G) (Fig. 5A, lanes 1 and 2, respectively). A two- to threefold-greater level of uspA1::cat mRNA was also observed in O35E.118CAT (10 G) compared to the level detected in O35E.135CAT (9 G), and this effect was seen using both a uspA1-specific probe (Fig. 5A, lanes 3 and 4, respectively) and a probe corresponding to the promoterless cat cartridge (Fig. 5C, lanes 3 and 4, respectively). A uspA2-specific probe was used to demonstrate that an equivalent amount of RNA from each of the respective strains was analyzed (Fig. 5B, lanes 1 to 4).
|
Effect of UspA1 phase variation on the adherence of M. catarrhalis to human epithelial cells in vitro. Isolate O35E.135 (9 G) exhibited a fourfold decrease in attachment to Chang cells relative to the level obtained with O35E.118 (10 G) (Table 2). By comparison, the lack of expression of UspA1 in the isogenic mutant strain O35E.1 caused a 45-fold decrease in adherence to Chang monolayers (Table 2). Proof that the observed attachment ability of isolate O35E.135 (9 G) was the result of the low-level expression of UspA1 was obtained by using the reporter construct O35E.135CAT which has nine G residues in its poly(G) tract but cannot express any functional UspA1 protein; this latter strain had an attachment level similar to that obtained with the uspA1 mutant O35E.1 (Table 2). Similar results were obtained when the strain O12E.44 (10 G) and its UspA1 phase variant O12E.77 (9 G) were analyzed in this same manner (Table 2).
To eliminate the possibility that phase variants expressing higher levels of UspA1 were the organisms that actually attached to the Chang monolayers incubated with isolate O35E.135 (9 G), bacteria attached to the Chang cells were recovered as individual colonies which were then passaged once on a brain heart infusion agar plate. Whole-cell lysates, as well as uspA1 amplicons, were generated from these colonies. All three of the adherent O35E.118 (10 G) isolates that were tested in this manner produced wild-type levels of UspA1 (Fig. 6A and B, lanes 1 to 3), and the uspA1 poly(G) tract in each of these three isolates contained 10 G residues (Fig. 6D, lines 1 to 3). All of the adherent O35E.135 (9 G) isolates that were analyzed, however, still expressed greatly reduced amounts of UspA1 (Fig. 6A and B, lanes 4 to 6) and their uspA1 poly(G) tracts contained 9 G residues (Fig. 6D, lines 3 to 6). The reactivity of MAb 10F3 with the CopB outer membrane protein was again used to confirm that equivalent amounts of cell lysate were analyzed (Fig. 6C).
|
Expression of wild-type and mutated uspA1 genes in H. influenzae. To determine whether the length of the poly(G) tract would affect expression of the uspA1 gene in a heterologous genetic background, the uspA1 genes from isolates O35E.118 (10 G) and O35E.135 (9 G) were cloned into H. influenzae DB117. These two cloned PCR products, derived from the use of the oligonucleotide primers P7 and P8 (Fig. 2B), did not contain the native uspA1 promoter region and were inserted in the same orientation into the tetracycline resistance gene in pACYC184.
Recombinant H. influenzae clones containing pELU1-10 G (Fig. 7C, lane 4; encodes O35E.118 uspA1) and pELU1-9 G (Fig. 7C, lane 3; encodes O35E.135 uspA1) were isolated on the basis of their reactivity with the UspA1-reactive MAb 17C7 in the colony blot RIA. In this assay, a significant difference was observed in the relative levels of UspA1 expressed by the two recombinant strains (Fig. 7C, lanes 3 and 4). Western blot analysis of whole-cell lysates prepared from H. influenzae DB117 (pELU1-10 G) demonstrated that MAb 17C7 bound an approximately 125-kDa UspA1 antigen (Fig. 7A, lane 4). In contrast, expression of UspA1 by H. influenzae DB117(pELU1-9 G) was not detected by Western blot analysis (Fig. 7A, lane 3). The reactivity of polyclonal antibodies with the H. influenzae P2 major outer membrane protein was used to demonstrate that equivalent amounts of cell lysate were analyzed (Fig. 7B). Northern blot analysis of these two strains revealed less uspA1 mRNA in H. influenzae DB117(pELU1-9 G) (Fig. 7E, lane 3) than in H. influenzae DB117(pELU1-10 G) (Fig. 7E, lane 4). Detection of mRNA from the vector-based cat gene was used to confirm that equivalent amounts of total RNA were analyzed in these experiments (Fig. 7D). Finally, H. influenzae DB117(pACYC184) was included in these experiments as a negative control (Fig. 7, lane 1).
|
| |
DISCUSSION |
|---|
|
|
|---|
The data presented in this study indicate that expression of the
M. catarrhalis UspA1 protein is subject to phase variation, resulting in greatly reduced levels of this antigen on the surface of
the organism. This phenomenon could be correlated with changes in the
number of G residues contained in a region [i.e., the poly(G) tract]
located 30 nt upstream from the uspA1 translational start codon. The uspA1 poly(G) tracts of most M. catarrhalis wild-type strains characterized to date (i.e., O35E,
O12E, TTA37, and O46E) were found to contain 10 G residues. All
isolates of these four strains which expressed reduced levels of UspA1
had 9 G residues in their uspA1 poly(G) tracts. Colony blot
RIA combined with Western blot and nucleotide sequence analyses of
isolates derived from O35E.118 (10 G) and O35E.135 (9 G) indicated the
rate of switching from 10 G
9 G residues to be 3.7 × 10
2 and the frequency of the 9 G
10 G conversion to be
9.7 × 10
3 (data not shown). It should also be
noted, with all of the wild-type M. catarrhalis strains used
in this study, colonies which completely lacked expression of the UspA1
protein were never detected regardless of the length of the
uspA1 poly(G) tract. Therefore, variable expression of the
UspA1 protein appeared to oscillate only between HIGH and LOW phases.
Extended homogeneous stretches of purines or pyrimidines have been shown to be involved in the molecular mechanisms by which expression of surface-exposed structures of several gram-negative pathogens undergoes phase variation (20). These homopolymeric tracts appear to be more prone to transitory base-pair misalignment, also referred to as slipped-strand mispairing, during DNA replication, which results in the addition or the removal of one or more of the repeated nucleotide residues. Depending on its location within a gene, variation in the length of a homopolymeric nucleotide tract can alter translation of ORFs or influence the transcription of genes (20).
With regard to homopolymeric nucleotide tracts involved in controlling expression of surface antigens, N. meningitidis possesses genes whose expression is controlled by these elements at either the transcriptional or translational levels. For example, biosynthesis of the lipopolysaccharide terminal structure lacto-N-neotetraose is subject to high-frequency ON-OFF phase variation, controlled at the level of translation, that involves a homopolymeric G tract located inside the first ORF of the meningococcal lgtABE locus (22, 23). Poly(G) tracts containing either 5 or 14 G residues maintain an intact lgtA ORF and can be correlated with the presence of lacto-N-neotetraose on the surface of N. meningitidis isolates. In contrast, lgtA alleles containing 9, 10, 12, or 13 G residues were predicted to be out of frame and isolates containing these poly(G) tracts did not express lipopolysaccharide molecules containing lacto-N-neotetraose. Interestingly, meningococcal isolates containing shorter lgtA poly(G) tracts consisting of five residues were found to constitutively express lacto-N-neotetraose. It was inferred from this observation that shorter homopolymeric tracts are less sensitive to slipped-strand mispairing and that expression of genes containing shorter tracts is more stable (23). Other examples of phase-variable expression of antigens controlled by a translational frameshift mechanism and involving a poly(G) tract include the N. meningitidis (27) and N. gonorrhoeae (9) outer membrane hemoglobin-binding protein HpuA, the N. meningitidis outer membrane hemoglobin-binding protein HmbR (27), and a 200-kDa outer membrane protein of M. catarrhalis (Sasaki et al., Abstr. 99th Gen. Meet. Am. Soc. Microbiol. 1999).
Variation in the length of homopolymeric nucleotide tracts can also
control gene expression at the level of transcription. Expression of
the class 1 outer membrane porin (PorA) of N. meningitidis was shown to display three distinct levels which could be correlated with the number of G residues present in a poly(G) tract located directly between the
35 and
10 regions of the porA
promoter (42). The presence of 11, 10, or 9 G residues in
the porA promoter resulted in high-level, medium-level, or
no expression of porA mRNA, respectively, which in turn
resulted in corresponding levels of PorA in the outer membrane of
N. meningitidis. Other examples of phase-variable expression
of antigens controlled by a transcriptional mechanism through
slipped-strand mispairing within a homopolymeric tract include the
N. meningitidis Opc outer membrane protein
(40); the Bordetella pertussis Fim2, Fim3, and
FimX fimbrial subunits (44); and the Mycoplasma
hyorhinis Vlp lipoproteins (45). It should be noted
that in all of the aforementioned examples, the homopolymeric tracts
are positioned upstream from the transcriptional start site of each
gene and between the
35 and
10 regions of their respective promoters.
The present study contains the first report of phase-variable expression of an M. catarrhalis surface-exposed antigen that is controlled at the level of transcription by variation in a homopolymeric nucleotide tract. Specifically, a decrease in the number of G residues in the poly(G) tract (i.e., from 10 to 9) exerted a significant effect on the level of uspA1 mRNA that could be detected in Northern blot analysis (Fig. 4). Additional quantitative analyses using slot blot hybridization and a cat reporter construct (Fig. 5), as well as primer extension experiments (Fig. 2), confirmed the existence of a difference in the levels of transcription of the uspA1 genes containing 10 and 9 G residues in their respective poly(G) tracts. The apparent discrepancies between the results obtained with the latter three methods (i.e., two- to threefold differences between 10 G and 9 G isolates) and that obtained with Northern blot analysis (i.e., no detectable uspA1 mRNA in the 9 G isolate) are likely the result of differences in the relative sensitivities of these methods. It is worth nothing that the differences between the 10 G and 9 G isolates detected with Northern blot analysis (Fig. 4) were more similar to the protein expression data, where Western blot analysis (Fig. 4) indicated a sixfold difference and the indirect antibody accessibility assay (Table 2) suggested an eightfold difference in UspA1 expression.
The changes in the number of G residues within the poly(G) tract in
these isolates is likely the result of slipped-strand mispairing,
although no experiments were performed in this study to address this
specific issue. The molecular mechanism by which the addition or
removal of a single residue within the uspA1 poly(G) tract
affects transcription of this gene, however, remains unclear. In
related phase-variation systems, homopolymeric tracts were located
between the
35 and
10 promoter regions of their respective genes.
Variation in the length of these tracts has been proposed to affect
binding of RNA polymerase to the promoter (11, 40, 42-45). In contrast, the M. catarrhalis uspA1
poly(G) tract was determined to be located 168 nt downstream of the
transcriptional start site of the gene and 30 nt upstream of the ORF.
Therefore, it is unlikely that variation in the length of the
uspA1 poly(G) tract would directly affect the binding of RNA
polymerase to the
35 and
10 sequences of the uspA1 gene.
It is possible that the addition or removal of residues within the
uspA1 poly(G) tract may affect the binding of a
transcriptional activator [i.e., when the poly(G)tract contains 10 G
residues] or repressor [i.e., when the poly(G)tract contains 9 G
residues]. Alternatively, changes in the number of G residues could
affect the stability of the uspA1 mRNA. However, attempts to
address this last issue by using S1 nuclease protection assays after
rifampin treatment of the M. catarrhalis cells were
inconclusive (data not shown).
Site-directed mutagenesis of the poly(G) tract in a recombinant uspA1 gene in H. influenzae DB117 determined that not only changes in length but also changes in the composition of the poly(G) tract adversely affected expression of both uspA1 mRNA and UspA1 protein (Fig. 7). Our results also indicated that the absence of the poly(G) tract and upstream DNA in DB117(pELU1-NOG) resulted in expression of uspA1 mRNA and UspA1 protein at levels greater than those expressed by H. influenzae DB117(pELU1-10 G) (Fig. 7, lanes 8 and 4, respectively). At this time, we do not know whether this increase in expression is a consequence of eliminating the poly(G) tract or simply the result of placing the uspA1 ORF in closer proximity to a plasmid-based promoter.
While it is clear that a reduction in the number of G residues from 10 to 9 in the poly(G) tract of the uspA1 gene in strains O35E, O12E, TTA37, and O46E reduced the expression of UspA1, it must be noted that two other wild-type M. catarrhalis strains (ATCC 25238 and P44) were identified that had only 6 or 7 G residues, respectively, in their uspA1 poly(G) tracts and yet still readily expressed UspA1 (data not shown). This finding indicates that either relatively short poly(G) tracts (i.e., six or seven residues) have no deleterious effect on expression of UspA1 or that there is something in the genetic background of these two strains that allows high-level expression of UspA1 despite the presence of the very short poly(G) tract. Isolates expressing significantly lower levels of UspA1, however, were not identified among the approximately 10,000 colonies of both M. catarrhalis ATCC 25238 (6 G) and P44 (7 G) that were tested in the colony blot RIA (data not shown). The failure to detect isolates of ATCC 25238 and P44 that expressed reduced levels of UspA1 raises the possibility that phase variation of UspA1 expression may not occur in these two strains. Alternatively, the frequency of phase variation in these two strains may simply be too low to be detected by the method (i.e., colony blot RIA) used in this study.
The M. catarrhalis UspA1 protein has been shown to function
as an adhesin in vitro (26). Since bacterial adherence is
likely an important first step in colonization of the upper respiratory tract by M. catarrhalis, the UspA1 protein may play a
pivotal role in the development of infection by this gram-negative
pathogen. The UspA1 protein, however, has also been shown to be
immunogenic and to stimulate the production of biologically relevant
antibodies (10, 31, 32, 39). The data presented in this
study clearly indicate that, even though phase variation of UspA1
(i.e., 10 G
9 G) resulted in greatly reduced levels of the protein
being expressed on the surface of the bacterium, these phase variants were still capable of adhering to human epithelial cells in vitro, albeit at a reduced level (Table 2). Thus, phase-variable expression of
UspA1 may enable a population of M. catarrhalis to establish a balance between the requirement for adherence to human epithelial cells in order to colonize its human host and the necessity to evade
the host immune response in order to persist and subsequently cause
infection. Phase variation of a bacterial surface antigen that is
regulated at the level of transcription has been reported to occur in
vivo; this involves the HMW1 and HMW2 adhesins of nontypeable H. influenzae (13). Whether phase variation of the M. catarrhalis UspA1 protein occurs in vivo remains to be determined.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by U.S. Public Health Service grant AI36344 to E.J.H.
We thank Jo Latimer and Sheryl Lumbley for technical assistance and Irene Rombel and Ross Chambers for helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Hamon Building, NA6.200, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9048. Phone: (214) 648-5974. Fax: (214) 648-5905. E-mail: eric.hansen{at}UTSouthwestern.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aebi, C.,
E. R. Lafontaine,
L. D. Cope,
J. L. Latimer,
S. R. Lumbley,
G. H. McCracken, Jr., and E. J. Hansen.
1998.
Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis O35E.
Infect. Immun.
66:3113-3119 |
| 2. | Aebi, C., I. Maciver, J. L. Latimer, L. D. Cope, M. K. Stevens, S. E. Thomas, G. H. McCracken, Jr., and E. J. Hansen. 1997. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect. Immun. 65:4367-4377[Abstract]. |
| 3. | Aebi, C., B. Stone, M. Beucher, L. D. Cope, I. Maciver, S. E. Thomas, G. H. McCracken, Jr., P. F. Sparling, and E. J. Hansen. 1996. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect. Immun. 64:2024-2030[Abstract]. |
| 4. | Bartos, L. C., and T. F. Murphy. 1988. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 158:761-765[Medline]. |
| 5. | Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media pathogens. Pediatr. Infect. Dis. J. 11:S7-S11[Medline]. |
| 6. | Bonnah, R. A., R. H. Yu, H. Wong, and A. B. Schryvers. 1998. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb. Pathog. 24:89-100[CrossRef][Medline]. |
| 7. | Campagnari, A. A., T. F. Ducey, and C. A. Rebmann. 1996. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrance of Moraxella (Branhamella) catarrhalis, binds human transferrin. Infect. Immun. 64:3920-3924[Abstract]. |
| 8. |
Campagnari, A. A.,
K. L. Shanks, and D. W. Dyer.
1994.
Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production.
Infect. Immun.
62:4909-4914 |
| 9. |
Chen, C.-J.,
C. Elkins, and P. F. Sparling.
1998.
Phase variation of hemoglobin utilization in Neisseria gonorrhoeae.
Infect. Immun.
66:987-993 |
| 10. |
Chen, D.,
V. Barniak,
K. R. VanDerMeid, and J. C. McMichael.
1999.
The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.
Infect. Immun.
67:1310-1316 |
| 11. |
Citti, C.,
R. Watson-McKown,
M. Droesse, and K. S. Wise.
2000.
Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis.
J. Bacteriol.
182:1356-1363 |
| 12. |
Cope, L. D.,
E. R. Lafontaine,
C. A. Slaughter,
C. A. Hasemann, Jr.,
C. Aebi,
F. W. Henderson, and G. H. McCracken, Jr.
1999.
Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.
J. Bacteriol.
181:4026-4034 |
| 13. |
Dawid, S.,
S. J. Barenkamp, and J. W. St. Geme, III.
1999.
Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes.
Proc. Natl. Acad. Sci. USA
96:1077-1082 |
| 14. |
Enright, M. C., and H. McKenzie.
1997.
Moraxella (Branhamella) catarrhalis clinical and molecular aspects of a rediscovered pathogen.
J. Med. Microbiol.
46:360-371[Abstract].
|
| 15. | Fitzgerald, M., R. Mulcahy, S. Murphy, C. Keane, D. Coakley, and T. Scott. 1997. A 200 kDa protein is associated with haemagglutinating isolates of Moraxella (Branhamella) catarrhalis. FEMS Immunol. Med. Microbiol. 18:209-216[CrossRef][Medline]. |
| 16. |
Gulig, P. A.,
G. H. McCracken, Jr.,
C. F. Frisch,
K. H. Johnston, and E. J. Hansen.
1982.
Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.
Infect. Immun.
37:82-88 |
| 17. | Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149[Medline]. |
| 18. |
Hansen, E. J.,
S. E. Pelzel,
K. Orth,
C. R. Moomaw,
J. D. Radolf, and C. A. Slaughter.
1989.
Structural and antigenic conservation of the P2 porin protein among strains of Haemophilus influenzae type b.
Infect. Immun.
57:3270-3275 |
| 19. |
Helminen, M. E.,
I. Maciver,
J. L. Latimer,
L. D. Cope,
G. H. McCracken, Jr., and E. J. Hansen.
1993.
A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.
Infect. Immun.
61:2003-2010 |
| 20. |
Henderson, I. R.,
P. Owen, and J. P. Nataro.
1999.
Molecular switches the ON and OFF of bacterial phase variation.
Mol. Microbiol.
33:919-932[CrossRef][Medline].
|
| 21. |
Hsiao, C. B.,
S. Sethi, and T. F. Murphy.
1995.
Outer membrane protein CD of Branhamella catarrhalis sequence conservation in strains recovered from the human respiratory tract.
Microb. Pathog.
19:215-225[CrossRef][Medline].
|
| 22. | Jennings, M. P., D. W. Hood, I. R. Peak, M. Virji, and E. R. Moxon. 1995. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol. Microbiol. 18:729-740[CrossRef][Medline]. |
| 23. |
Jennings, M. P.,
Y. N. Srikhanta,
E. R. Moxon,
M. Kramer,
J. T. Poolman,
B. Kuipers, and L. P. van der.
1999.
The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.
Microbiology
145(Pt. 11):3013-3021 |
| 24. |
Klingman, K. L., and T. F. Murphy.
1994.
Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis.
Infect. Immun.
62:1150-1155 |
| 25. | Kyd, J. M., A. W. Cripps, and T. F. Murphy. 1998. Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance. J. Med. Microbiol. 47:159-168[Abstract]. |
| 26. |
Lafontaine, E. R.,
L. D. Cope,
C. Aebi,
J. L. Latimer,
G. H. McCracken, Jr., and E. J. Hansen.
2000.
The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.
J. Bacteriol.
182:1364-1373 |
| 27. | Lewis, L. A., M. Gipson, K. Hartman, T. Ownbey, J. Vaughn, and D. W. Dyer. 1999. Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2. Mol. Microbiol. 32:977-989[CrossRef][Medline]. |
| 28. |
Luke, N. R., and A. A. Campagnari.
1999.
Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.
Infect. Immun.
67:5815-5819 |
| 29. |
Lukomski, S.,
R. A. Hull, and S. I. Hull.
1996.
Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette.
J. Bacteriol.
178:240-247 |
| 30. | Markwell, M. A. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210[CrossRef][Medline]. |
| 31. | Mathers, K., M. Leinonen, and D. Goldblatt. 1999. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media. Pediatr. Infect. Dis. J. 18:982-988[CrossRef][Medline]. |
| 32. |
McMichael, J. C.,
M. J. Fiske,
R. A. Fredenburg,
D. N. Chakravarti,
K. R. VanDerMeid,
V. Barniak,
J. Caplan,
E. Bortell,
S. Baker,
R. Arumugham, and D. Chen.
1998.
Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope.
Infect. Immun.
66:4374-4381 |
| 33. |
Murphy, T. F.
1996.
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.
Microbiol. Rev.
60:267 |
| 34. |
Murphy, T. F.,
C. Kirkham,
A. DeNardin, and S. Sethi.
1999.
Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.
Infect. Immun.
67:4578-4585 |
| 35. |
Myers, L. E.,
Y.-P. Yang,
R. P. Du,
Q. J. Wang,
R. E. Harkness,
A. B. Schryvers,
M. H. Klein, and S. M. Loosmore.
1998.
The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.
Infect. Immun.
66:4183-4192 |
| 36. |
Patrick, C. C.,
A. Kimura,
M. A. Jackson,
L. Hermanstorfer,
A. Hood,
G. H. McCracken, Jr., and E. J. Hansen.
1987.
Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae.
Infect. Immun.
55:2902-2911 |
| 37. | Pelton, S. I., and J. O. Klein. 1999. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr. Infect. Dis. J. 18:926-935[CrossRef][Medline]. |
| 38. |
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 39. |
Samukawa, T.,
N. Yamanaka,
S. Hollingshead,
K. Klingman, and H. Faden.
2000.
Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract.
Infect. Immun.
68:1569-1573 |
| 40. | Sarkari, J., N. Pandit, E. R. Moxon, and M. Achtman. 1994. Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol. Microbiol. 13:207-217[Medline]. |
| 41. |
Setlow, J. K.,
D. C. Brown,
M. E. Boling,
A. Mattingly, and M. P. Gordon.
1968.
Repair of deoxyribonucleic acid in Haemophilus influenzae.
J. Bacteriol.
95:546-558 |
| 42. |
van der Ende, A.,
C. T. Hopman,
S. Zaat,
B. B. Essink,
B. Berkhout, and J. Dankert.
1995.
Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the 10 and 35 regions of the promoter.
J. Bacteriol.
177:2475-2480 |
| 43. |
Washburn, L. R.,
K. E. Weaver,
E. J. Weaver,
W. Donelan, and S. Al Sheboul.
1998.
Molecular characterization of Mycoplasma arthritidis variable surface protein MAA2.
Infect. Immun.
66:2576-2586 |
| 44. | Willems, R., A. Paul, H. van der Heide, A. R. ter Avest, and F. R. Mooi. 1990. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J. 9:2803-2809[Medline]. |
| 45. | Yogev, D., R. Rosengarten, R. Watson-McKown, and K. S. Wise. 1991. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences. EMBO J. 10:4069-4079[Medline]. |
This article has been cited by other articles: